measuregroup/AID211096

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103297644_AID211096_PMID10509910_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103298130_AID211096_PMID10509910_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103297576_AID211096_PMID10509910_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103297641_AID211096_PMID10509910_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103735076_AID211096_PMID10509910_VALUE5
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ04750
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	In vitro inhibitory activity against topoisomerase I (Topo I) by using relaxation assay
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103297576 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103735076 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103298130 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103297641 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103297644
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID211096

Total number of triples: 15.